A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion - Concepedia

Concepedia

Publication | Open Access

A phase I clinical and pharmacokinetic study of the new topoisomerase inhibitor GI147211 given as a 72-h continuous infusion

DOI Full Paper Access

23

Citations

19

References

1998

Year

Luis Paz‐Ares, Robert L. Kunka, D Demaria, J Cassidy, M Alden, P.A. Beranek, S.B. Kaye, Diane E. Littlefield, D Reilly, Scott Depee,

British Journal of Cancer

MedicinePharmacokinetic StudyClinical PharmacologyPharmacotherapy72-H Continuous InfusionPharmacologyDrug DiscoveryTranslational Pharmacology

References

	Year	Citations

Page 1

Page 1